UNLABELLED: Chronic kidney disease (CKD) accelerates cardiovascular disease. The mechanisms that explain this independent, excess risk associated with CKD have not been fully elucidated. OBJECTIVES: We propose that impaired regression of atherosclerosis in renal disease represents a novel risk factor for the heightened morbidity and mortality and resistance to treatment observed in patients with CKD. METHODS AND RESULTS: Using a transplant model to study atherosclerosis regression, we transplanted atheromatous aortic segments generated in Apolipoprotein E knock-out (ApoE(-/-)) mice, into either control or moderately uremic, normolipidemic, wild-type mice. In non-uremic mice, lesions regressed 55%, whereas lesions in uremic mice increased in size by 17% (p<0.01 for control vs. uremic). The lesions in uremic mice were also characterized by a greater presence of macrophages (36,300 microm(2) vs. 12,600 microm(2), p<0.01). This finding was despite upregulation of chemokine receptor 7 (CCR7), normally a migration factor, in uremic lesion macrophages. Gene expression analysis of lesion macrophages showed relative down-regulation of serum response factor (SRF) target genes in the uremic group, consistent with impaired CCR7 signaling. CONCLUSION: Moderate kidney disease inhibits regression of atherosclerosis in a mouse transplant model. This inhibition may be a result of impaired CCR7 signaling. Copyright 2009 Elsevier Ireland Ltd. All rights reserved.
UNLABELLED: Chronic kidney disease (CKD) accelerates cardiovascular disease. The mechanisms that explain this independent, excess risk associated with CKD have not been fully elucidated. OBJECTIVES: We propose that impaired regression of atherosclerosis in renal disease represents a novel risk factor for the heightened morbidity and mortality and resistance to treatment observed in patients with CKD. METHODS AND RESULTS: Using a transplant model to study atherosclerosis regression, we transplanted atheromatous aortic segments generated in Apolipoprotein E knock-out (ApoE(-/-)) mice, into either control or moderately uremic, normolipidemic, wild-type mice. In non-uremic mice, lesions regressed 55%, whereas lesions in uremic mice increased in size by 17% (p<0.01 for control vs. uremic). The lesions in uremic mice were also characterized by a greater presence of macrophages (36,300 microm(2) vs. 12,600 microm(2), p<0.01). This finding was despite upregulation of chemokine receptor 7 (CCR7), normally a migration factor, in uremic lesion macrophages. Gene expression analysis of lesion macrophages showed relative down-regulation of serum response factor (SRF) target genes in the uremic group, consistent with impaired CCR7 signaling. CONCLUSION: Moderate kidney disease inhibits regression of atherosclerosis in a mouse transplant model. This inhibition may be a result of impaired CCR7 signaling. Copyright 2009 Elsevier Ireland Ltd. All rights reserved.
Authors: Ziad A Massy; Ognen Ivanovski; Thao Nguyen-Khoa; Jesus Angulo; Dorota Szumilak; Nadya Mothu; Olivier Phan; Michel Daudon; Bernard Lacour; Tilman B Drüeke; Martin S Muntzel Journal: J Am Soc Nephrol Date: 2004-11-24 Impact factor: 10.121
Authors: Susanne Bro; Jacob F Bentzon; Erling Falk; Claus B Andersen; Klaus Olgaard; Lars B Nielsen Journal: J Am Soc Nephrol Date: 2003-10 Impact factor: 10.121
Authors: Eugene Trogan; Zahi A Fayad; Vitalii V Itskovich; Juan-Gilberto S Aguinaldo; Venkatesh Mani; John T Fallon; Igor Chereshnev; Edward A Fisher Journal: Arterioscler Thromb Vasc Biol Date: 2004-07-15 Impact factor: 8.311
Authors: Igor Chereshnev; Eugene Trogan; Sabina Omerhodzic; Vitalii Itskovich; Juan-Gilberto Aguinaldo; Zahi A Fayad; Edward A Fisher; Ernane D Reis Journal: J Surg Res Date: 2003-05-15 Impact factor: 2.192
Authors: Steven E Reis; Marian B Olson; Linda Fried; Virginia Reeser; Sunil Mankad; Carl J Pepine; Richard Kerensky; C Noel Bairey Merz; Barry L Sharaf; George Sopko; William J Rogers; Richard Holubkov Journal: Circulation Date: 2002-06-18 Impact factor: 29.690
Authors: Richard L Amdur; Harold I Feldman; Elizabeth A Dominic; Amanda H Anderson; Srinivasan Beddhu; Mahboob Rahman; Myles Wolf; Muredach Reilly; Akinlolu Ojo; Raymond R Townsend; Alan S Go; Jiang He; Dawei Xie; Sally Thompson; Matthew Budoff; Scott Kasner; Paul L Kimmel; John W Kusek; Dominic S Raj Journal: Am J Kidney Dis Date: 2018-12-10 Impact factor: 8.860
Authors: Eva Gravesen; Maria Lerche Mace; Anders Nordholm; Jacob Hofman-Bang; Keith Hruska; Carsten Haagen Nielsen; Andreas Kjær; Klaus Olgaard; Ewa Lewin Journal: PLoS One Date: 2018-01-05 Impact factor: 3.240
Authors: Yoshiyasu Minami; Zhao Wang; Aaron D Aguirre; Daniel S Ong; Chong-Jin Kim; Shiro Uemura; Tsunenari Soeda; Hang Lee; James Fujimoto; Ik-Kyung Jang Journal: J Am Heart Assoc Date: 2017-11-01 Impact factor: 5.501